ACETYLSALICYLIC ACID /100 mg Enteric Coated Tablet

Non-Steroidal Antirheumatics

Atypical Antipsychotics - Schizophrenia

Abdi İbrahim announces plans to use solar and wind energy in all of its facilities from January 1, 2020  onwards

Abdi İbrahim, the leader of the Turkish pharmaceutical industry, were laid by the pharmacist Abdi İbrahim Bey who initiated the journey of healing by establishing a small pharmacy in 1912 in İstanbul’s Küçükmustafapaşa neighborhood. Today, collaborating with 30 licensors and developing its own products, Abdi İbrahim has the widest product portfolio in the industry with its 200+ brands and 450+ products in chemical Rx, biotechnological and OTC categories.
Thanks to its strong vision and dynamic structure, Abdi İbrahim has maintained its leadership in the Turkish pharmaceutical industry since 2002. The largest employer in the industry with 4,600 highly qualified employees, the company also stands out with the largest marketing and sales force in the industry.
At its Istanbul Esenyurt Production Complex, Abdi İbrahim manufactures its own products as well as those of a large number of global pharma companies as a CMO, including chemical Rx, biotechnologicals, hormones, ophthalmic agents and sterile products. Abdi İbrahim's R&D Center is the first accredited pharmaceutical R&D Center in Turkey.
As an EU-approved GMP facility, the Esenyurt Production Complex holds GMP certificates for Turkey, Canada, Portugal, Brazil, Russia, Ukraine, South Africa, Jordan, Peru, Saudi Arabia, Iraq, Tunisia, the Gulf countries and United Arab Emirates.
Furthermore, the company has R&D Centers and production facilities in Kazakhstan and Algeria.